Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-520-5000
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicole Kim is a gastroenterology and hepatology specialist based in Seattle, Washington. A member of the faculty at UW Medicine/Harborview Medical Center, she has additional expertise in liver transplantation. She received her MD and MPH in Health Services from the University of Washington, followed by multiple fellowships in areas such as transplant hepatology and research. Dr. Kim's extensive publication record delves into topics like racial disparities in liver cancer care and hepatocellular carcinoma screening.
Education & Training
University of WashingtonFellowship, Transplant Hepatology, 2022 - 2023- University of WashingtonFellowship, Research, 2020 - 2022
- University of WashingtonFellowship, Gastroenterology, 2018 - 2021
University of California (San Francisco)Residency, Internal Medicine, 2015 - 2018- University of Washington School of MedicineClass of 2015, MD
University of WashingtonMPH, Health Services, 2013 - 2014
Certifications & Licensure
WA State Medical License 2018 - 2027
CA State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- The Diagnosis and Staging of Hepatocellular Carcinoma: A Review of Current Practices.Philip Vutien, Nicole J Kim, Mindie H Nguyen
Clinics in Liver Disease. 2025-02-01 - Screening high-risk Veterans for cirrhosis: taking a stepwise population health approach.Jonathan Dounel, Carolyn Lamorte, Heather Patton, Ponni Perumalswami, Heather McCurdy
BMC Health Services Research. 2025-01-29 - Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death.Philip Vutien, Abbey Barnard Giustini, Nicole J Kim, Andrew M Moon, Chun-Nan Hsu
Hepatology. 2024-12-17
Press Mentions
Liver Cancer Risk Persists After DAA Treatment for HCVJuly 14th, 2022
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
